D.R.L., S.L.P., K.O.B., C.M.G., G.R.W., and M.B.D. are members of the Collaborative Clinical Research Network of Friedreich Ataxia (established and supported by the Friedreich Ataxia Research Alliance, USA).
FXN methylation predicts expression and clinical outcome in Friedreich ataxia†
Article first published online: 20 APR 2012
Copyright © 2011 American Neurological Association
Annals of Neurology
Volume 71, Issue 4, pages 487–497, April 2012
How to Cite
Evans-Galea, M. V., Carrodus, N., Rowley, S. M., Corben, L. A., Tai, G., Saffery, R., Galati, J. C., Wong, N. C., Craig, J. M., Lynch, D. R., Regner, S. R., Brocht, A. F. D., Perlman, S. L., Bushara, K. O., Gomez, C. M., Wilmot, G. R., Li, L., Varley, E., Delatycki, M. B. and Sarsero, J. P. (2012), FXN methylation predicts expression and clinical outcome in Friedreich ataxia. Ann Neurol., 71: 487–497. doi: 10.1002/ana.22671
- Issue published online: 20 APR 2012
- Article first published online: 20 APR 2012
- Accepted manuscript online: 25 NOV 2011 08:37AM EST
- Manuscript Accepted: 4 NOV 2011
- Manuscript Revised: 10 OCT 2011
- Manuscript Received: 16 JUN 2011
Additional supporting information can be found in the online version of this article.
|ANA_22671_sm_SuppFig2.tif||215K||Supporting Information Figure 2|
|ANA_22671_sm_SuppFig4.tif||534K||Supporting Information Figure 4|
|ANA_22671_sm_SuppFig5.tif||69K||Supporting Information Figure 5|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.